{"text_format":"3","workbook":"xls","n_sheets":6,"sheets":["Canonical Pathways","Functions and disease","Hoja1","Specific functions","Tox functions","Networks"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Canonical Pathways","index":0,"n_rows":100,"n_cols":4,"rows_kept":100,"flags":["formulas_cached_only"]}
["© 2000-2016 QIAGEN. All rights reserved."]
["Ingenuity Canonical Pathways"," -log(p-value)","Ratio","Molecules"]
["Remodeling of Epithelial Adherens Junctions",{"v":6.25,"d":"6.25E+00"},{"v":0.0588,"d":"5.88E-02"},"ACTR2,ARPC2,ACTB,ACTG1"]
["RhoGDI Signaling",{"v":6.12,"d":"6.12E+00"},{"v":0.0279,"d":"2.79E-02"},"ACTR2,ARPC2,ACTB,ACTG1,ARHGDIB"]
["Clathrin-mediated Endocytosis Signaling",{"v":6.01,"d":"6.01E+00"},{"v":0.0266,"d":"2.66E-02"},"ACTR2,ALB,ARPC2,ACTB,ACTG1"]
["Death Receptor Signaling",{"v":5.72,"d":"5.72E+00"},{"v":0.0435,"d":"4.35E-02"},"ACTB,ACTG1,CASP7,ARHGDIB"]
["Epithelial Adherens Junction Signaling",{"v":4.9,"d":"4.90E+00"},{"v":0.027,"d":"2.70E-02"},"ACTR2,ARPC2,ACTB,ACTG1"]
["Tight Junction Signaling",{"v":4.69,"d":"4.69E+00"},{"v":0.024,"d":"2.40E-02"},"PPP2CB,PPP2R4,ACTB,ACTG1"]
["Role of CHK Proteins in Cell Cycle Checkpoint Control",{"v":4.67,"d":"4.67E+00"},{"v":0.0545,"d":"5.45E-02"},"PPP2CB,PCNA,PPP2R4"]
["Integrin Signaling",{"v":4.32,"d":"4.32E+00"},{"v":0.0192,"d":"1.92E-02"},"ACTR2,ARPC2,ACTB,ACTG1"]
["Caveolar-mediated Endocytosis Signaling",{"v":4.3,"d":"4.30E+00"},{"v":0.0411,"d":"4.11E-02"},"ALB,ACTB,ACTG1"]
["Actin Cytoskeleton Signaling",{"v":4.22,"d":"4.22E+00"},{"v":0.0182,"d":"1.82E-02"},"ACTR2,ARPC2,ACTB,ACTG1"]
["HIPPO signaling",{"v":4.07,"d":"4.07E+00"},{"v":0.0345,"d":"3.45E-02"},"PPP2CB,YWHAG,PPP2R4"]
["Regulation of Actin-based Motility by Rho",{"v":3.98,"d":"3.98E+00"},{"v":0.0323,"d":"3.23E-02"},"ACTR2,ARPC2,ACTB"]
["p70S6K Signaling",{"v":3.6,"d":"3.60E+00"},{"v":0.024,"d":"2.40E-02"},"PPP2CB,YWHAG,PPP2R4"]
["PI3K/AKT Signaling",{"v":3.57,"d":"3.57E+00"},{"v":0.0234,"d":"2.34E-02"},"PPP2CB,YWHAG,PPP2R4"]
["Cell Cycle Regulation by BTG Family Proteins",{"v":3.26,"d":"3.26E+00"},{"v":0.0571,"d":"5.71E-02"},"PPP2CB,PPP2R4"]
["NRF2-mediated Oxidative Stress Response",{"v":3.14,"d":"3.14E+00"},{"v":0.0167,"d":"1.67E-02"},"PRDX1,ACTB,ACTG1"]
["Mechanisms of Viral Exit from Host Cells",{"v":3.12,"d":"3.12E+00"},{"v":0.0488,"d":"4.88E-02"},"ACTB,ACTG1"]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages",{"v":3.1,"d":"3.10E+00"},{"v":0.0161,"d":"1.61E-02"},"PPP2CB,ALB,PPP2R4"]
["ERK/MAPK Signaling",{"v":3.07,"d":"3.07E+00"},{"v":0.0157,"d":"1.57E-02"},"PPP2CB,YWHAG,PPP2R4"]
["AMPK Signaling",{"v":3.04,"d":"3.04E+00"},{"v":0.0154,"d":"1.54E-02"},"PPP2CB,PPP2R4,ACTB"]
["Breast Cancer Regulation by Stathmin1",{"v":3.03,"d":"3.03E+00"},{"v":0.0152,"d":"1.52E-02"},"STMN1,PPP2CB,PPP2R4"]
["MSP-RON Signaling Pathway",{"v":3.01,"d":"3.01E+00"},{"v":0.0426,"d":"4.26E-02"},"ACTB,ACTG1"]
["Actin Nucleation by ARP-WASP Complex",{"v":2.85,"d":"2.85E+00"},{"v":0.0357,"d":"3.57E-02"},"ACTR2,ARPC2"]
["Mitotic Roles of Polo-Like Kinase",{"v":2.71,"d":"2.71E+00"},{"v":0.0303,"d":"3.03E-02"},"PPP2CB,PPP2R4"]
["Agrin Interactions at Neuromuscular Junction",{"v":2.66,"d":"2.66E+00"},{"v":0.0286,"d":"2.86E-02"},"ACTB,ACTG1"]
["Cyclins and Cell Cycle Regulation",{"v":2.57,"d":"2.57E+00"},{"v":0.0256,"d":"2.56E-02"},"PPP2CB,PPP2R4"]
["Ceramide Signaling",{"v":2.51,"d":"2.51E+00"},{"v":0.0238,"d":"2.38E-02"},"PPP2CB,PPP2R4"]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",{"v":2.47,"d":"2.47E+00"},{"v":0.0227,"d":"2.27E-02"},"PPP2CB,PPP2R4"]
["Crosstalk between Dendritic Cells and Natural Killer Cells",{"v":2.45,"d":"2.45E+00"},{"v":0.0222,"d":"2.22E-02"},"ACTB,ACTG1"]
["FAK Signaling",{"v":2.45,"d":"2.45E+00"},{"v":0.0222,"d":"2.22E-02"},"ACTB,ACTG1"]
["Dopamine Receptor Signaling",{"v":2.43,"d":"2.43E+00"},{"v":0.0217,"d":"2.17E-02"},"PPP2CB,PPP2R4"]
["Virus Entry via Endocytic Pathways",{"v":2.4,"d":"2.40E+00"},{"v":0.0211,"d":"2.11E-02"},"ACTB,ACTG1"]
["VEGF Signaling",{"v":2.38,"d":"2.38E+00"},{"v":0.0204,"d":"2.04E-02"},"ACTB,ACTG1"]
["Telomerase Signaling",{"v":2.37,"d":"2.37E+00"},{"v":0.0202,"d":"2.02E-02"},"PPP2CB,PPP2R4"]
["Paxillin Signaling",{"v":2.35,"d":"2.35E+00"},{"v":0.0198,"d":"1.98E-02"},"ACTB,ACTG1"]
["CDK5 Signaling",{"v":2.33,"d":"2.33E+00"},{"v":0.0194,"d":"1.94E-02"},"PPP2CB,PPP2R4"]
["Rac Signaling",{"v":2.3,"d":"2.30E+00"},{"v":0.0187,"d":"1.87E-02"},"ACTR2,ARPC2"]
["fMLP Signaling in Neutrophils",{"v":2.24,"d":"2.24E+00"},{"v":0.0174,"d":"1.74E-02"},"ACTR2,ARPC2"]
["14-3-3-mediated Signaling",{"v":2.21,"d":"2.21E+00"},{"v":0.0168,"d":"1.68E-02"},"YWHAG,VIM"]
["CD28 Signaling in T Helper Cells",{"v":2.18,"d":"2.18E+00"},{"v":0.0163,"d":"1.63E-02"},"ACTR2,ARPC2"]
["Cardiac β-adrenergic Signaling",{"v":2.07,"d":"2.07E+00"},{"v":0.0142,"d":"1.42E-02"},"PPP2CB,PPP2R4"]
["Cellular Effects of Sildenafil (Viagra)",{"v":2.06,"d":"2.06E+00"},{"v":0.0141,"d":"1.41E-02"},"ACTB,ACTG1"]
["Regulation of eIF4 and p70S6K Signaling",{"v":2.02,"d":"2.02E+00"},{"v":0.0133,"d":"1.33E-02"},"PPP2CB,PPP2R4"]
["Synaptic Long Term Depression",{"v":2.01,"d":"2.01E+00"},{"v":0.0132,"d":"1.32E-02"},"PPP2CB,PPP2R4"]
["Tec Kinase Signaling",{"v":1.96,"d":"1.96E+00"},{"v":0.0125,"d":"1.25E-02"},"ACTB,ACTG1"]
["Germ Cell-Sertoli Cell Junction Signaling",{"v":1.95,"d":"1.95E+00"},{"v":0.0123,"d":"1.23E-02"},"ACTB,ACTG1"]
["Gap Junction Signaling",{"v":1.92,"d":"1.92E+00"},{"v":0.0119,"d":"1.19E-02"},"ACTB,ACTG1"]
["Cdc42 Signaling",{"v":1.92,"d":"1.92E+00"},{"v":0.0118,"d":"1.18E-02"},"ACTR2,ARPC2"]
["Wnt/β-catenin Signaling",{"v":1.91,"d":"1.91E+00"},{"v":0.0118,"d":"1.18E-02"},"PPP2CB,PPP2R4"]
["BER pathway",{"v":1.89,"d":"1.89E+00"},{"v":0.0769,"d":"7.69E-02"},"PCNA"]
["Dopamine-DARPP32 Feedback in cAMP Signaling",{"v":1.89,"d":"1.89E+00"},{"v":0.0114,"d":"1.14E-02"},"PPP2CB,PPP2R4"]
["Ephrin Receptor Signaling",{"v":1.88,"d":"1.88E+00"},{"v":0.0113,"d":"1.13E-02"},"ACTR2,ARPC2"]
["Calcium Transport I",{"v":1.86,"d":"1.86E+00"},{"v":0.0714,"d":"7.14E-02"},"ANXA5"]
["Sertoli Cell-Sertoli Cell Junction Signaling",{"v":1.84,"d":"1.84E+00"},{"v":0.0108,"d":"1.08E-02"},"ACTB,ACTG1"]
["Agranulocyte Adhesion and Diapedesis",{"v":1.82,"d":"1.82E+00"},{"v":0.0105,"d":"1.05E-02"},"ACTB,ACTG1"]
["mTOR Signaling",{"v":1.81,"d":"1.81E+00"},{"v":0.0104,"d":"1.04E-02"},"PPP2CB,PPP2R4"]
["Leukocyte Extravasation Signaling",{"v":1.76,"d":"1.76E+00"},{"v":0.0098,"d":"9.80E-03"},"ACTB,ACTG1"]
["Mismatch Repair in Eukaryotes",{"v":1.75,"d":"1.75E+00"},{"v":0.0556,"d":"5.56E-02"},"PCNA"]
["GADD45 Signaling",{"v":1.73,"d":"1.73E+00"},{"v":0.0526,"d":"5.26E-02"},"PCNA"]
["Endoplasmic Reticulum Stress Pathway",{"v":1.69,"d":"1.69E+00"},{"v":0.0476,"d":"4.76E-02"},"CASP7"]
["Tumoricidal Function of Hepatic Natural Killer Cells",{"v":1.63,"d":"1.63E+00"},{"v":0.0417,"d":"4.17E-02"},"CASP7"]
["Xenobiotic Metabolism Signaling",{"v":1.52,"d":"1.52E+00"},{"v":0.00725,"d":"7.25E-03"},"PPP2CB,PPP2R4"]
["Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells",{"v":1.5,"d":"1.50E+00"},{"v":0.0312,"d":"3.12E-02"},"CASP7"]
["TWEAK Signaling",{"v":1.48,"d":"1.48E+00"},{"v":0.0294,"d":"2.94E-02"},"CASP7"]
["TNFR1 Signaling",{"v":1.32,"d":"1.32E+00"},{"v":0.0204,"d":"2.04E-02"},"CASP7"]
["Cell Cycle: G2/M DNA Damage Checkpoint Regulation",{"v":1.32,"d":"1.32E+00"},{"v":0.0204,"d":"2.04E-02"},"YWHAG"]
["Myc Mediated Apoptosis Signaling",{"v":1.25,"d":"1.25E+00"},{"v":0.0172,"d":"1.72E-02"},"YWHAG"]
["ERK5 Signaling",{"v":1.21,"d":"1.21E+00"},{"v":0.0156,"d":"1.56E-02"},"YWHAG"]
["PEDF Signaling",{"v":1.17,"d":"1.17E+00"},{"v":0.0141,"d":"1.41E-02"},"CASP7"]
["Axonal Guidance Signaling",{"v":1.16,"d":"1.16E+00"},{"v":0.00455,"d":"4.55E-03"},"ACTR2,ARPC2"]
["Role of BRCA1 in DNA Damage Response",{"v":1.13,"d":"1.13E+00"},{"v":0.0128,"d":"1.28E-02"},"ACTB"]
["Apoptosis Signaling",{"v":1.07,"d":"1.07E+00"},{"v":0.0112,"d":"1.12E-02"},"CASP7"]
["p53 Signaling",{"v":1.03,"d":"1.03E+00"},{"v":0.0102,"d":"1.02E-02"},"PCNA"]
["IGF-1 Signaling",{"v":1.03,"d":"1.03E+00"},{"v":0.0101,"d":"1.01E-02"},"YWHAG"]
["Amyotrophic Lateral Sclerosis Signaling",{"v":0.996,"d":"9.96E-01"},{"v":0.00935,"d":"9.35E-03"},"CASP7"]
["Sphingosine-1-phosphate Signaling",{"v":0.973,"d":"9.73E-01"},{"v":0.00885,"d":"8.85E-03"},"CASP7"]
["Oxidative Phosphorylation",{"v":0.952,"d":"9.52E-01"},{"v":0.0084,"d":"8.40E-03"},"NDUFA10"]
["Atherosclerosis Signaling",{"v":0.932,"d":"9.32E-01"},"8E-03","ALB"]
["phagosome maturation",{"v":0.925,"d":"9.25E-01"},{"v":0.00787,"d":"7.87E-03"},"PRDX1"]
["LXR/RXR Activation",{"v":0.922,"d":"9.22E-01"},{"v":0.00781,"d":"7.81E-03"},"ALB"]
["Hereditary Breast Cancer Signaling",{"v":0.913,"d":"9.13E-01"},{"v":0.00763,"d":"7.63E-03"},"ACTB"]
["D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis","9E-01",{"v":0.00741,"d":"7.41E-03"},"PPP2R4"]
["D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis","9E-01",{"v":0.00741,"d":"7.41E-03"},"PPP2R4"]
["FXR/RXR Activation",{"v":0.895,"d":"8.95E-01"},{"v":0.0073,"d":"7.30E-03"},"ALB"]
["IL-12 Signaling and Production in Macrophages",{"v":0.895,"d":"8.95E-01"},{"v":0.0073,"d":"7.30E-03"},"ALB"]
["D-myo-inositol-5-phosphate Metabolism",{"v":0.852,"d":"8.52E-01"},{"v":0.00658,"d":"6.58E-03"},"PPP2R4"]
["3-phosphoinositide Degradation",{"v":0.85,"d":"8.50E-01"},{"v":0.00654,"d":"6.54E-03"},"PPP2R4"]
["3-phosphoinositide Biosynthesis",{"v":0.81,"d":"8.10E-01"},{"v":0.00592,"d":"5.92E-03"},"PPP2R4"]
["Acute Phase Response Signaling",{"v":0.805,"d":"8.05E-01"},{"v":0.00585,"d":"5.85E-03"},"ALB"]
["Calcium Signaling",{"v":0.772,"d":"7.72E-01"},{"v":0.00538,"d":"5.38E-03"},"TPM2"]
["Endothelin-1 Signaling",{"v":0.769,"d":"7.69E-01"},{"v":0.00535,"d":"5.35E-03"},"CASP7"]
["Mitochondrial Dysfunction",{"v":0.767,"d":"7.67E-01"},{"v":0.00532,"d":"5.32E-03"},"NDUFA10"]
["RAR Activation",{"v":0.749,"d":"7.49E-01"},{"v":0.00508,"d":"5.08E-03"},"ACTB"]
["Superpathway of Inositol Phosphate Compounds",{"v":0.713,"d":"7.13E-01"},{"v":0.00463,"d":"4.63E-03"},"PPP2R4"]
["Huntington's Disease Signaling",{"v":0.68,"d":"6.80E-01"},{"v":0.00426,"d":"4.26E-03"},"CASP7"]
["Glucocorticoid Receptor Signaling",{"v":0.611,"d":"6.11E-01"},{"v":0.00356,"d":"3.56E-03"},"ACTB"]
["Molecular Mechanisms of Cancer",{"v":0.506,"d":"5.06E-01"},{"v":0.00268,"d":"2.68E-03"},"CASP7"]
["Protein Kinase A Signaling",{"v":0.483,"d":"4.83E-01"},{"v":0.00251,"d":"2.51E-03"},"YWHAG"]

{"sheet":"Functions and disease","index":1,"n_rows":55,"n_cols":3,"rows_kept":55,"flags":["formulas_cached_only"]}
["© 2000-2016 QIAGEN. All rights reserved."]
["Category"," p-value","Molecules"]
["Skeletal and Muscular Disorders","6.11E-07-4.15E-02","STMN1,PCNA,ALB,PRDX1,TPT1,ACTB,NDUFA10,VIM,TPM2,ACTG1,CASP7,ARHGDIB"]
["Connective Tissue Disorders","9.39E-07-2.06E-02","PCNA,ALB,PRDX1,ACTB,VIM,TPM2,ACTG1,ARHGDIB"]
["Developmental Disorder","9.39E-07-3.99E-02","PCNA,ALB,TPT1,ACTB,NDUFA10,VIM,TPM2,ACTG1,ARHGDIB"]
["Organismal Injury and Abnormalities","9.39E-07-4.75E-02","SRI,ACTR2,HNRNPF,YWHAG,TPT1,PRDX1,ACTB,VIM,TPM2,PPA1,ARHGDIB,STMN1,PPP2CB,ALB,PCNA,PPP2R4,ARPC2,ANXA5,NDUFA10,HNRNPH3,ACTG1,CASP7"]
["Cellular Movement","6.44E-06-4.28E-02","STMN1,ACTR2,ALB,TPT1,PRDX1,ACTB,ANXA5,ARPC2,VIM,ARHGDIB"]
["Immunological Disease","6.44E-06-4.56E-02","STMN1,PCNA,ALB,PRDX1,ACTB,ANXA5,VIM,TPM2,ACTG1,ARHGDIB,CASP7"]
["Inflammatory Disease","6.44E-06-3.9E-02","ALB,PRDX1,ACTB,VIM,TPM2,ARHGDIB,CASP7"]
["Inflammatory Response","6.44E-06-3.61E-02","ALB,TPT1,PRDX1,ACTB,ANXA5,VIM,TPM2,ACTG1,ARHGDIB,CASP7"]
["Cellular Assembly and Organization","1.97E-05-4.94E-02","STMN1,ACTR2,SRI,ALB,YWHAG,ACTB,ARPC2,ANXA5,VIM,TPM2,ACTG1,ARHGDIB"]
["Cellular Function and Maintenance","1.97E-05-4.94E-02","ACTR2,SRI,YWHAG,PRDX1,ACTB,VIM,TPM2,ARHGDIB,STMN1,PCNA,ALB,ANXA5,ARPC2,ACTG1,CASP7"]
["Connective Tissue Development and Function","1.97E-05-4.18E-02","STMN1,ACTR2,PRDX1,ARPC2,ACTB,VIM"]
["Cell Morphology","2.62E-05-4.83E-02","STMN1,ACTR2,PPP2CB,PCNA,ALB,YWHAG,PRDX1,ACTB,ANXA5,ARPC2,VIM,CASP7"]
["Cell-To-Cell Signaling and Interaction","2.62E-05-4.56E-02","STMN1,ACTR2,ALB,YWHAG,TPT1,ANXA5,ACTB,ARPC2,VIM,ACTG1,CASP7"]
["Tissue Development","1.49E-04-4.66E-02","SRI,ACTR2,YWHAG,TPT1,ACTB,VIM,TPM2,ARHGDIB,STMN1,ALB,PCNA,ANXA5,ARPC2,ACTG1"]
["Free Radical Scavenging","9.92E-04-4.47E-02","ALB,PRDX1,ACTB,ARHGDIB"]
["Gastrointestinal Disease","9.92E-04-4.66E-02","STMN1,PCNA,ALB,YWHAG,PRDX1,ACTB,VIM,TPM2,ACTG1,CASP7"]
["Hepatic System Disease","9.92E-04-3.9E-02","ALB,YWHAG,PRDX1,VIM,ACTG1,CASP7"]
["Lipid Metabolism","9.92E-04-4.03E-02","STMN1,ALB,YWHAG,ANXA5,VIM"]
["Organismal Development","9.92E-04-4.37E-02","SRI,ALB,PCNA,TPT1,ANXA5,ACTB,VIM,ACTG1,ARHGDIB,CASP7"]
["Post-Translational Modification","9.92E-04-9.92E-04","ALB"]
["Reproductive System Disease","9.92E-04-4.55E-02","STMN1,HNRNPF,ACTR2,ALB,PCNA,PRDX1,ANXA5,NDUFA10,VIM,TPM2,ACTG1,ARHGDIB"]
["Tissue Morphology","9.92E-04-4.75E-02","STMN1,TPT1,PRDX1,VIM,ARHGDIB"]
["Tumor Morphology","9.92E-04-4.75E-02","STMN1,ALB,PRDX1,VIM"]
["Embryonic Development","1.46E-03-4.37E-02","SRI,ALB,PCNA,TPT1,ANXA5,VIM,ACTG1,ARHGDIB"]
["Organ Development","1.46E-03-4.37E-02","STMN1,SRI,PCNA,ALB,ANXA5,VIM,ACTG1,ARHGDIB,CASP7"]
["Skeletal and Muscular System Development and Function","1.46E-03-4.66E-02","STMN1,SRI,YWHAG,ANXA5,VIM,ACTG1"]
["Nervous System Development and Function","1.5E-03-4.56E-02","STMN1,ALB,YWHAG,ACTB,VIM"]
["Cardiovascular Disease","1.98E-03-3.7E-02","ALB,PRDX1,ANXA5,VIM,ARHGDIB"]
["Dermatological Diseases and Conditions","1.98E-03-4.47E-02","ALB,VIM"]
["Digestive System Development and Function","1.98E-03-1.97E-02","ALB,VIM,CASP7"]
["Gene Expression","1.98E-03-2.74E-02","SRI,ALB,PCNA,YWHAG,PRDX1"]
["Hematological System Development and Function","1.98E-03-4.28E-02","PCNA,ALB,TPT1,PRDX1,ANXA5,ACTB,ACTG1,ARHGDIB"]
["Immune Cell Trafficking","1.98E-03-4.28E-02","ALB,TPT1,PRDX1,ACTB,ANXA5"]
["Cellular Development","2.39E-03-4.85E-02","STMN1,ALB,PCNA,YWHAG,TPT1,ACTB,VIM,TPM2,ACTG1,CASP7"]
["Cellular Growth and Proliferation","2.39E-03-4.37E-02","STMN1,HNRNPF,ALB,PCNA,YWHAG,PRDX1,TPT1,ACTB,VIM,ACTG1,ARHGDIB,CASP7"]
["Lymphoid Tissue Structure and Development","4.95E-03-3.13E-02","TPT1,ARHGDIB"]
["Organismal Functions","4.95E-03-2.16E-02","ANXA5,VIM"]
["RNA Trafficking","4.95E-03-4.85E-02","ALB"]
["Endocrine System Development and Function","5.19E-03-1.77E-02","YWHAG,VIM"]
["Vitamin and Mineral Metabolism","5.19E-03-1.77E-02","YWHAG,VIM"]
["RNA Post-Transcriptional Modification","5.36E-03-3.03E-02","HNRNPF,ALB,HNRNPH3"]
["Hepatic System Development and Function","5.94E-03-1.97E-02","ALB,CASP7"]
["Cell Signaling","6.92E-03-1.84E-02","STMN1,PPP2CB,ARHGDIB"]
["Nutritional Disease","6.92E-03-8.89E-03","ALB"]
["Renal and Urological System Development and Function","6.92E-03-2.26E-02","STMN1,VIM"]
["Reproductive System Development and Function","8.65E-03-3.32E-02","ALB,PCNA,ARHGDIB"]
["Organ Morphology","1.09E-02-3.13E-02","ALB,VIM,ARHGDIB,CASP7"]
["Organismal Survival","1.17E-02-1.61E-02","PCNA,TPT1,PRDX1,ACTB,VIM,ACTG1,ARHGDIB,CASP7"]
["Protein Trafficking","1.38E-02-1.38E-02","SRI"]
["Hair and Skin Development and Function","1.67E-02-3.13E-02","ANXA5,VIM"]
["Hypersensitivity Response","2.16E-02-4.28E-02","ALB,TPT1"]
["Hematopoiesis","3.03E-02-3.99E-02","ANXA5,ARHGDIB"]
["Humoral Immune Response","3.03E-02-3.03E-02","ARHGDIB"]

{"sheet":"Hoja1","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}

{"sheet":"Specific functions","index":3,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}

{"sheet":"Tox functions","index":4,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}

{"sheet":"Networks","index":5,"n_rows":0,"n_cols":0,"rows_kept":0,"hidden":true,"flags":["formulas_cached_only"]}